Clinical Trial Update: Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age [Phase 3]

View source ↗

Summary

Phase 3 efficacy trial of a vaccine to prevent herpes zoster in adults over 40 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Herpes Zoster | Phase 3 | Status: COMPLETED